Image

A Price Too Far: Breaking The Silence On End-Of-Life Costs

Watch Video
PDF
How much would you pay to live six months longer? Once a taboo subject, the soaring cost of endof-life health care and treatment has become amatter for urgent discussion - the last year of life costs on average as much as all the previous years combined! And countless new but exorbitantly priced treatments are bound to add to the bill in the very near future. Our journalists investigate Perjeta, a breast cancer drug developed by Roche that extends the life of patients on average by 6 months… at a cost of 70,000 euros.
Year
2017
Production
RTS
Journalist
Isabelle Ducret
Resolution
HD
Collection

Related Titles

See below for your title to view